Distinct promoter usage of mdm2 gene in human breast cancer

Oncology Reports

Volumn 9, Issue 3, 2002, Pages 557-563

  Okumura, Naoki ^a,b   Saji, Shigehira ^a,b,c   Eguchi, Hidetaka ^b   Nakashima, Shigeru ^a   Saji, Shigetoyo ^a   Hayashi, Shin Ichi ^b  

^a GIFU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b SAITAMA CANCER CENTER   (Japan)

^c TOKYO METROPOLITAN KOMAGOME HOSPITAL   (Japan)

Author keywords

Breast cancer; Estrogen receptor; mdm2; p53; Promoter

Indexed keywords

ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; MESSENGER RNA;

ADULT; AGED; ARTICLE; BIOLOGICAL MODEL; BIOSYNTHESIS; BREAST TUMOR; CELL CULTURE; FEMALE; GENETICS; HUMAN; METABOLISM; MIDDLE AGED; MUTATION; NUCLEOTIDE SEQUENCE; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR GENE;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; DNA MUTATIONAL ANALYSIS; ESTROGEN RECEPTOR ALPHA; FEMALE; GENES, P53; HUMANS; MIDDLE AGED; MODELS, GENETIC; MUTATION; PROMOTER REGIONS (GENETICS); RECEPTORS, ESTROGEN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 0036584680     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Oliner JD, Kinzler KW, Melzer PS, George DL and Vogelstein B: Amplification of a gene encoding a p53-associated protein in human sarcomas. Nature 358: 80-83, 1992.
2. Cordon-Cardo C, Latres E, Drobnjak M, Oliva MR, Pollack D, Woodruff JM, Marechal VJ, Chen J, Brennan MF and Levine AJ: Molecular abnormalities of mdm2 and p53 genes in adult soft tissue sarcomas. Cancer Res 54: 794-799, 1994.
3. Quesnel B, Preudhomme C, Fouriner J, Fenaux P and Peyrat JP: MDM2 gene amplification in human breast cancer. Eur J Cancer 30A: 982-984, 1994. (Pubitemid 24256248)
4. McCann AH, Kirley A, Carney DN, Corbally N, Magee HM, Keating G and Dervan PA: Amplification of the MDM2 gene in human breast cancer and its association with MDM2 and p53 protein status. Br J Cancer 71: 981-985, 1995.
5. Fakharzadeh SS, Trusko SP and George DL: Tumorigenic potential associated with enhanced expression of a gene that is amplified in a mouse tumor cell line. EMBO J 10: 1565-1569, 1991. (Pubitemid 21905621)
6. Momand J, Zambetti GP, Olson DC, George D and Levine AJ: The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell 69: 1237-1245, 1992.
7. Boddy MN, Freemont PS and Borden KL: The p53-associated protein MDM2 contains a newly characterized zinc-binding domain called the RING finger. Trends Biochem Sci 19: 198-199, 1994.
8. Kussie PH, Gorina S, Marechal V, Elenbaas B, Moreau J, Levine AJ and Pavletich NP: Structure of the MDM2 oncoprotein bound to the p53 tumor suppressor transactivation domain. Science 274: 948-953, 1996. (Pubitemid 26398409)
9. Haupt Y, Maya R, Karaz A and Oren M: Mdm2 promotes the rapid degradation of p53. Nature 387: 296-299, 1997. (Pubitemid 27220766)
10. Honda R, Tanaka H and Yasuda H: Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53. FEBS Lett 420: 25-27, 1997. (Pubitemid 28037193)
11. Barak Y, Juven T, Haffner R and Oren M: Mdm2 expression is induced by wild-type p53 activity. EMBO J 12: 461-468, 1993. (Pubitemid 23073692)
12. Juven T, Barak Y, Zauberman A, George DL and Oren M: Wild-type p53 can mediate sequence-specific transactivation of an internal promoter within the mdm2 gene. Oncogene 8: 3411-3416, 1993. (Pubitemid 23342640)
13. Zauberman A, Flusberg D, Haupt Y, Barak Y and Oren M: A functional p53-responsive intronic promoter is contained within the human mdm2 gene. Nucleic Acids Res 23: 2584-2592, 1995.
14. Landers JE, Cassel SL and George DL: Translational enhancement of mdm2 oncogene expression in human tumor cells containing a stabilized wild-type p53 protein. Cancer Res 57: 3562-3568, 1997. (Pubitemid 27355508)
15. Brown CY, Mize GJ, Pineda M, George DL and Morris DR: Role of two upstream open reading frames in the translational control of oncogene mdm2. Oncogene 18: 5631-5637, 1999. (Pubitemid 29497597)
16. Inada K, Toi M, Yamamoto Y, Suzuki A, Kurisaki T, Suzuki H and Tominaga T: Immunocytochemical analysis of MDM2 protein expression and its relevance to tumor angiogenesis in primary breast cancer. Oncol Rep 3: 667-671, 1996. (Pubitemid 26201952)
17. Baunoch DA, Watkins LF, Tewari A, Reece MT, Adams L, Stack R, Brown A, Jones L, Christian D, Latif NA, Lawrence WD and Lane MA: MDM2 overexpression in benign and malignant lesions of the human breast: association with ERα expression. Int J Oncol 8: 895-899, 1996. (Pubitemid 26144910)
18. Hideshima T, Baba M and Shirakusa T: The expression of MDM2 and p53 protein in breast carcinoma. Oncol Rep 4: 297-300, 1997. (Pubitemid 27106946)
19. Marchetti A, Buttitta F, Girlando S, Dalla Palma P, Pellegrini S, Fina P, Doglioni C, Bevilacqua G and Barbareschi M: mdm2 gene alterations and mdm2 protein expression in breast carcinomas. J Pathol 175: 31-38, 1995.
20. Saji S, Nakashima S, Hayashi S, Toi M, Saji S and Nozawa Y: Overexpression of MDM2 in MCF-7 promotes both growth advantage and p53 accumulation in response to estradiol. Jpn J Cancer Res 90: 210-218, 1999. (Pubitemid 29112322)
21. Saji S, Okumura N, Eguchi H, Nakashima S, Suzuki A, Toi M, Nozawa Y, Saji S and Hayashi S: MDM2 enhances the function of estrogen receptor alpha in human breast cancer cells. Biochem Biophys Res Commun 281: 259-265, 2001. (Pubitemid 32924428)
22. Gudas JM, Nguyen H, Kiein RC, Katayose D, Seth P and Cowan KH: Differential expression of multiple MDM2 messenger RNAs and proteins in normal and tumorigenic breast epithelial cells. Clin Cancer Res 1:71-80, 1995.
23. Sheikh MS, Shao ZM, Hussain A and Fontana JA: The p53-binding protein MDM2 gene is differentially expressed in human breast carcinoma. Cancer Res 53: 3226-3228, 1993. (Pubitemid 23223285)
24. Yoshida T, Eguchi H, Nakachi K, Tanimoto K, Higashi Y, Suemasu K, Iino Y, Morishita Y and Hayashi S: Distinct mechanisms of loss of estrogen receptor alpha gene expression in human breast cancer: methylation of the gene and alteration of trans-acting factors. Carcinogenesis 21: 2193-2201, 2000. (Pubitemid 32049225)
25. Chomczynski P and Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159, 1987. (Pubitemid 17064313)
26. Hayashi S, Imai K, Suga K, Kurihara T, Higashi Y and Nakachi K: Two promoters in expression of estrogen receptor messenger RNA in human breast cancer. Carcinogenesis 18: 459-464, 1997. (Pubitemid 28132480)
27. Ercolani L, Florence B, Denaro M and Alexander M: Isolation and complete sequence of a functional human glyceraldehyde-3-phosphate dehydrogenase gene. J Biol Chem 263: 15335-15341, 1988.
28. Orita M, Iwahana H, Kanazawa H, Hayashi K and Sekiya T: Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. Proc Natl Acad Sci USA 86: 2766-2770, 1989. (Pubitemid 19112622)
29. Tokuchi Y, Hashimoto T, Kobayashi Y, Hayashi M, Nishida K, Hayashi S, Imai K, Nakachi K, Ishikawa Y, Nakagawa K, Kawakami Y and Tsuchiya E: The expression of p73 is increased in lung cancer, independent of p53 gene alteration. Br J Cancer 80: 1623-1629, 1999. (Pubitemid 29308646)
30. Coles C, Condie A, Chetty U, Steel CM, Evans HJ and Presser J: p53 mutations in breast cancer. Cancer Res 52: 5291-5298, 1992.
31. Gretarsdottir S, Tryggvadottir L, Jonasson JG, Sigurdsson H, Olafsdottir K, Agnarsson BA, Ogmundsdottir H and Eyfjord JE: TP53 mutation analyses on breast carcinomas: a study of paraffin-embedded archival material. Br J Cancer 74: 555-561, 1996. (Pubitemid 26279049)
32. Seshadri R, Leong AS, McCaul K, Firgaira FA, Setlur V and Horsfall DJ: Relationship between p53 gene abnormalities and other tumour characteristics in breast-cancer prognosis. Int J Cancer 69: 135-141, 1996. (Pubitemid 26164863)
33. Bull EK, Chakrabarty S, Brodsky I and Haines DS: mdm2-P2 transcript levels predict the functional activity of the p53 tumor suppressor in primary leukemic cells. Oncogene 16: 2249-2257, 1998. (Pubitemid 28220655)
34. Barak Y, Gottlieb E, Juven-Gershon T and Oren M: Regulation of mdm2 expression by p53: alternative promoters produce transcripts with non-identical translation potential. Genes Dev 8: 1739-1749, 1994. (Pubitemid 24265781)
35. Caleffi M, Teague MW, Jensen RA, Vnencak-Jones CL, Dupont WD and Pari FF: p53 gene mutations and steroid receptor status in breast cancer. Clinicopathologic correlations and prognostic assessment. Cancer 73: 2147-2156, 1994.
36. Faille A, De Cremoux P, Extra JM, Linares G, Espie M, Bourstyn E, De Rocquancourt A, Giacchetti S, Marty M and Calvo F: p53 mutations and overexpression in locally advanced breast cancers. Br J Cancer 69: 1145-1150, 1994.
37. Cuny M, Kramar A, Courjal F, Johannsdottir V, Iacopetta B, Fontaine H, Grenier J, Culine S and Theillet C: Relating genotype and phenotype in breast cancer: an analysis of the prognostic significance of amplification at eight different genes or loci and of p53 mutations. Cancer Res 60: 1077-1083, 2000. (Pubitemid 30129548)